Aging and cancer cell biology, 2009

Aging Cell

Volumn 8, Issue 3, 2009, Pages 221-225

  Campisi, Judith ^a,b   Yaswen, Paul ^b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

DNA damage response; FOXO transcription factors; Inflammation; Longevity; p53; PI3 kinases; Sirtuins; Telomeres; Tumor suppression

Indexed keywords

CYTOKINE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; SIRTUIN 1; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXO;

AGING; CALORIC RESTRICTION; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL AGING; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE RELEASE; CYTOLOGY; DEGENERATION; DISEASE ASSOCIATION; DNA DAMAGE; GENE FUNCTION; GENE MUTATION; HUMAN; INFLAMMATION; LIFESPAN; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE;

AGING; CELL AGING; CYTOKINES; HUMANS; LONGEVITY; NEOPLASMS; SIRTUIN 1; SIRTUINS; TELOMERE;

MAMMALIA;

EID: 66149173551     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2009.00475.x     Document Type: Review

References (34)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Furnagalli M, DaCosta M, Brown C, Popov N, Takastu Y, Yabuta N, Melamed J, d'Adda di Fagagna F, Bernard D, Hernando E, Gil J (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018.
2. Artandi SE, DePinho RA (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39-46.
3. Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, Gu W, Accili D (2008) SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333-341.
4. Beliveau A, Bassett E, Lo AT, Garbe J, Rubio MA, Bissell MJ, Campisi J, Yaswen P (2007) p53-dependent integration of telomere and growth factor deprivation signals. Proc. Natl Acad. Sci. USA 104, 4431-4436.
5. Blasco MA (2003) Mammalian telomeres and telomerase: Why they matter for cancer and aging. Eur. J. Cell Biol. 82, 441-446.
6. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, Gu W, Guarente L (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759-767.
7. Campisi J (2007) Aging and cancer cell biology, 2007. Aging Cell 6, 261-263.
8. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: When bad things happen to good cells. Nat. Rev. Mol. Cell. Biol. 8, 729-740.
9. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB (2005) Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123, 437-448.
10. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz D, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) A senescence-associated secretory phenotype reveals cell non-autonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
11. Deng CX (2009) SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 5, 147-152.
12. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, García-Echeverría C, Schultz PG, Reddy VA (2009) The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc. Natl Acad. Sci. USA 106, 268-273.
13. Finkel T, Serrano M, Blasco MA (2007) The common biology of cancer and ageing. Nature 448, 767-774.
14. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE 3, e2020.
15. Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA (2008) The longest telomeres: A general signature of adult stem cell compartments. Genes Dev. 22, 654-667.
16. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA (2001) Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619-2630.
17. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410-7425.
18. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70.
19. Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J (2003) Aging and genome maintenance: Lessons from the mouse? Science 299, 1355-1359.
20. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667.
21. Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet CJ, A AL, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.
22. Liu T, Liu PY, Marshall GM (2009) The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 69, 1702-1705.
23. McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu. Rev. Genet. 34, 331-358.
24. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, Yankner BA, Scully R, Prolla TA, Alt FW, Sinclair DA (2008) SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907-918.
25. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. USA 105, 9793-9798.
26. Prieur A, Peeper DS (2008) Cellular senescence in vivo: A barrier to tumorigenesis. Curr. Opin. Cell Biol. 20, 150-155.
27. Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J (2005) Cancer and aging: the importance of telomeres in genome maintenance. Int. J. Biochem. Cell Biol. 37, 977-990.
28. Suh Y, Atzmon G, Cho MO, Hwang D, Liu B, Leahy DJ, Barzilai N, Cohen P (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl Acad. Sci. USA 105, 3438-3442.
29. Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA (2008) Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell 135, 609-622.
30. Vijg J, Campisi J (2008) Puzzles, promises and a cure for ageing. Nature 454, 1065-1071.
31. Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C, Kim S, Xu X, Zheng Y, Chilton B, Jia R, Zheng ZM, Appella E, Wang XW, Ried T, Deng CX (2008a) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14, 312-323.
32. Wang RH, Zheng Y, Kim HS, Xu X, Cao L, Luhasen T, Lee MH, Xiao C, Vassilopoulos A, Chen W, Gardner K, Man YG, Hung MC, Finkel T, Deng CX (2008b) Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol. Cell 32, 11-20.
33. Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B, Curb JD (2008) FOXO3A genotype is strongly associated with human longevity. Proc. Natl Acad. Sci. USA 105, 13987-13992.
34. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP, Liang CC (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 80, 191-199.